LEADER 01350nam  2200361   450 
001 9910704334103321
005 20130521144332.0
035   $a(CKB)5470000002440346
035   $a(OCoLC)826774636
035   $a(EXLCZ)995470000002440346
100   $a20130205d2012      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDrug safety $ean update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010
210  1$aWashington :$cU.S. Government Printing Office,$d2012.
215   $a1 online resource (v, 81 pages)
300   $aTitle from title screen (viewed Feb. 5, 2013).
300   $aPaper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.
300   $a"Serial no. 111-103."
517   $aDrug safety 
606   $aDrugs$xSafety regulations$zUnited States
606   $aPharmaceutical policy$zUnited States
615  0$aDrugs$xSafety regulations
615  0$aPharmaceutical policy
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910704334103321
996   $aDrug safety$92379886
997   $aUNINA